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Abstract: Epithelial to mesenchymal transition (EMT) is a multipurpose process involved in wound
healing, development, and certain pathological processes, such as metastasis formation. The Tks4
scaffold protein has been implicated in cancer progression; however, its role in oncogenesis is not
well defined. In this study, the function of Tks4 was investigated in HCT116 colon cancer cells
by knocking the protein out using the CRISPR/Cas9 system. Surprisingly, the absence of Tks4
induced significant changes in cell morphology, motility, adhesion and expression, and localization
of E-cadherin, which are all considered as hallmarks of EMT. In agreement with these findings, the
marked appearance of fibronectin, a marker of the mesenchymal phenotype, was also observed in
Tks4-KO cells. Analysis of the expression of well-known EMT transcription factors revealed that
Snail2 was strongly overexpressed in cells lacking Tks4. Tks4-KO cells showed increased motility
and decreased cell–cell attachment. Collagen matrix invasion assays demonstrated the abundance of
invasive solitary cells. Finally, the reintroduction of Tks4 protein in the Tks4-KO cells restored the
expression levels of relevant key transcription factors, suggesting that the Tks4 scaffold protein has a
specific and novel role in EMT regulation and cancer progression.
Keywords: Tks4; scaffold protein; EMT; HCT116; motility; invasiveness
1. Introduction
Cellular plasticity enables cells to undergo major phenotypic changes under certain physiological
conditions. One such process is epithelial-mesenchymal transition (EMT). EMT occurs in multiple
biological processes, including wound healing, organ formation, embryogenesis, and the formation of
solid metastases. This transition is not necessarily permanent as the mesenchymal characteristics can
be reverted back to an epithelial phenotype [1–5].
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Epithelial cells undergoing EMT lose their apico-basal polarity and their cobblestone-like
arrangement disappears to give rise to an elongated spearhead-like morphology [6]. The expression of
cell–cell junction proteins is repressed, while the synthesis of extracellular matrix proteins (ECM) is
initiated [7]. This proteome remodeling is mainly facilitated by E-box-binding transcription factors, such
as Snail1 and Snail2/Slug, which downregulate E-cadherin expression [8–10]. Furthermore, Snail1/2
and Zeb1/2 can repress other tight junction components, such as connexins, occludins, and ZO-1,
among others [11]. The Twist family also plays a part in regulating E-cadherin expression by promoting
the expression of Snail transcription factors [12]. Simultaneously increased expression of mesenchymal
markers, including vimentin, fibronectin, and N-cadherin, leads to complete transformation [13].
Many signaling pathways can lead to EMT. Traditionally, developmental pathways have been viewed
as key players in this signal initiation, e.g., TGF-β, WNT, and NOTCH signaling, as well as pathways
involving various receptor tyrosine kinases (RTK) [14–20], including EGF, which can also facilitate
EMT induction [14,20].
Scaffold proteins control cellular signaling by interacting with and bringing various pathway
components, such as enzymes and regulatory proteins, into close proximity [21,22]. The protein
product of the SH3PXD2B gene, Tks4, belongs to the family of scaffold proteins [23]. Tks4 is involved
in podosome formation, cell migration, mesenchymal stem cell differentiation, adipose tissue beigeing,
and bone trabecular formation [23–29]. Inactivating mutations in the SH3PXD2B gene cause a rare
genetic disorder known as Frank-ter-Haar syndrome (FTHS, OMIM:249420) [30]. FTHS patients show
several serious symptoms related to altered tissue development, such as cardiac deficiencies, kyphosis,
shortened and bowing long bones, and craniofacial and dental abnormalities [31–35].
Tks5, a homolog of Tks4, has been implicated in cancer progression [36]. Matrigel invasion
assays with various human cancer cells revealed that Tks5 expression is vital for invadopodium
formation [36]. Further studies have demonstrated the clinical significance of Tks5 in a number of
different cancer types, including breast cancer, gliomas, and lung adenocarcinoma, as well as colon
and prostate cancer [37–40]. An elegant series of recent experiments showed that both Tks family
members (Tks4 and Tks5) play key roles in melanoma cell invasion and metastasis [27]. Furthermore,
both Tks proteins are highly expressed in human melanoma tissue, suggesting that the Tks proteins
are important regulators of melanoma growth [27].
In our study, the role of Tks4 in colon cancer cells was investigated. The scaffold protein was
deleted via the CRISPR/Cas9 system, and the effects of Tks4 deletion were investigated via a number
of different methods, including the characterization of cell morphology and motility, cell adhesion, and
spheroid formation, as well as the measurement of the expression levels of EMT-governing master
transcription factors. Our results show that loss of Tks4 in colon cancer cells induces an EMT-like
mesenchymal phenotype.
2. Materials and Methods
2.1. CRISPR/Cas9-Mediated Engineering of the HCT116 Cell Genome
HCT116 cells were maintained in McCoy’s 5A medium (Gibco, Paisley, UK) supplemented with
10% fetal bovine serum (FBS; Gibco) and antibiotics, penicillin and streptomycin (Sigma-Aldrich,
Schnelldorf, Germany). Cell number and viability were determined by the TC20 Automated Cell
Counter (Bio-Rad, Hercules, CA, USA) using 0.4% trypan blue dye exclusion. Cells were tested
routinely for Mycoplasma infection (MycoAlert™ mycoplasma detection kit, Lonza). Morphological
assessment was performed using an Olympus CKX41 inverted microscope.
HCT116 cells were transfected with pCMV-Cas9-GFP_SH3PXD2B (Sigma-Aldrich) using FuGENE
HD (Promega, Madison, WI, USA) transfection reagent. Two days after transfection, cells were passaged
and sorted for GFP expression (Attune FACSARIA III sorter). After sorting, the GFP-positive cells
were seeded as single-cell colonies (1 cell/100 µL) into three 96-well plates. After reaching confluency,
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cells were expanded and subjected to genotyping where genomic DNA (gDNA) was isolated using the
MasterPure DNA Purificaton Kit (Epicentre) following the manufacturer’s instructions.
DNA fragments of various sizes that covered the gRNA target region were amplified using
the primers: E2P2_F: ATAAGAATTCATTGTTTTCTGTGCGTGCCG and E2P2_R: TATGGATCCGC
TCACCAGCAAACACGATT. The PCR products were purified and digested with Eco72I (Thermo
Scientific), which has a digestion site that incorporates two nucleotides from the PAM sequence and is,
therefore, disrupted if Cas9 cleavage takes place (Figure S1). To confirm that the colonies had mutations
in both alleles, PCR products, that Eco72I was unable to digest, were sub-cloned into the pBluescript II
SK(+) plasmids and amplified in a bacterial host. Plasmid DNA was isolated from individual colonies
and then sequenced.
2.2. Cell Adhesion Assays
Vybrant Cell Adhesion Assays Kit (Molecular Probes) was used for cell adhesion measurements.
Cells were trypsinized, washed twice with phosphate-buffered saline (PBS), and then resuspended in
serum-free McCoy’s 5A medium (Gibco). The cells were labeled with calcein-AM dye (Sigma-Aldrich)
at a concentration of 0.25 µM for 30 min at 37 ◦C and then seeded into 96-well plates at a density of
10,000 cells/well. The plates were incubated for three hours, after which the non-adherent labeled cells
were carefully washed away with 200 µL of pre-warmed McCoy’s 5A medium. This washing step was
repeated three times. Finally, the medium was decanted and the wells were filled with 200 µL of PBS.
The fluorescence was measured at 517 nm using empty PBS-filled wells as a negative control.
2.3. Antibodies
Antibodies against Tks4 were purchased from Merck-Millipore (09-267) and Sigma-Aldrich
(A303-437A), the generation of the polyclonal anti-Tks4 antibody was described earlier [41]. Antibodies
α-tubulin (DM1A) and fibronectin (F7387) were obtained from Sigma-Aldrich. Antibodies against
E-cadherin (ab11512 and ab 15148), fibronectin (ab45688), and Snail1 (ab216347) were purchased
from Abcam.
2.4. Confocal Microscopy
Cells were seeded into 8-well µ-Slides (ibidi) at a density of 20,000 cells/well. The next day,
the medium was decanted and the cells were washed three times with 200 µL of pre-warmed PBS.
The cells were fixed in 4% para-formaldehyde solution for 20 min at room temperature, washed, and
then blocked with complete blocking solution (0.5% BSA, 5% FBS, 0.1% TritonX-100 in sterile PBS)
for one hour at room temperature. They were then incubated with the relevant primary antibodies
for one hour. After incubation, the cells were washed with PBS, and the corresponding secondary
antibodies were added, followed by incubation for one hour at room temperature. Imaging was carried
out using a ZEISS LSM-710 system (Carl Zeiss microscopy Gmbh, Jena, Germany) with a 40×/1.4
Plan-Apochromat oil immersion objective. Images were processed with ZEN (Carl Zeiss microscopy
Gmbh, Jena, Germany).
2.5. Extraction of Total RNA and RT-PCR Analysis
WT and Tks4-KO cells were lysed using TRIzol™ Reagent (Life Technologies, Carlsbad, CA, USA).
The total RNA was isolated using the Direct-zol® MiniPrep kit (Zymo Research, Irvine, CA, USA),
which was also used to prepare the total RNA samples. gDNA contamination was prevented via
in-column DNAse treatment. Complementary DNA (cDNA) was produced via reverse transcription of
1 µg of RNA using the First Strand cDNA Synthesis kit for RT-PCR (Roche, Basel, Switzerland) with the
provided random primers. The real-time PCR analyses were done using the StepOne™ Real-Time PCR
System (Life Technologies). Fold changes were determined via the 2−∆∆Ct method. Relative expression
levels are presented as the mean values ± S.D. of three independent experiments. Pre-developed
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TaqMan® assays for FN1 (Hs01549976_m1), SNAI1 (Hs00195591_m1), SNAI2 (Hs00161904_m1), TWIST
(Hs01675818_s1) and ACTB (Hs01060665_g1) were purchased from Applied Biosystems.
2.6. Western Blot Analysis
Before lysation with ice-cold harvest buffer (30 mM Tris (pH 7.5), with 100 mM NaCl, 1% Triton
X-100, 10 mM NaF, 1 mM Na3VO4, 1 mM EGTA, 2 mM 4-nitrophenyl phosphate, 10 mM benzamidine,
1 mM phenylmethylsulphonyl fluoride, 25 µg/mL Pepstatin A, 25 µg/mL trypsin inhibitor, and 25µg/mL
aprotinin), cells were washed with phosphate-buffered saline solution. Lysates were centrifuged at
14,000 rpm, 10 min at 4 ◦C. Sample loading was then added to the supernatants, followed by incubation
at 95 ◦C for 10 min. The total protein concentrations were determined using Bradford reagent. 30 µg of
each protein sample were subjected to SDS-PAGE using 10% gels. Nitrocellulose membranes were
blocked and incubated for 60 min with anti-Tks4 antibody at room temperature. After several washing
steps, the membranes were incubated for 30 min with horseradish peroxidase-conjugated secondary
antibody (GE Healthcare) and then washed three times for 10 min each. The proteins of interest were
visualized via enhanced chemiluminescence (ECL) detection reagents (Amersham, Little Chalfont,
UK). Chemiluminescent imaging was performed with a ChemiDoc MP system (Bio-Rad).
2.7. Construction of the pCAGIG_hTks4 Rescue Plasmid and Transient Tks4 Expression
The coding sequence of human Tks4 (hTks4) (Assembly: GCF_000001405.33, locus: NC_000005.10)
was sub-cloned into pcDNA3.1/TOPO-V5-His, as described earlier [41]. This construct was used
as a template to amplify the Tks4 coding sequence with the primers ATTAGATATCCGTAGAAT
CGAGACCGAGG and ATTAGAATTCAGCGCCACCATGCCGCCG. The produced amplicon was
sub-cloned into pCAGIG (AddGene plasmid id.: #11159) using EcoRI (Thermo Fisher) and BamHI
(Thermo Fisher). An internal EcoRI site in the Tks4 coding sequence was mutated from GAATTC to
GAGTTC using the Q5 site-directed mutagenesis kit (NEB) according to the manufacturer’s instructions.
100 µL of OptiMem (Gibco) medium was mixed with 3 µL of X-tremeGene transfection reagent (Roche)
and 1.6 µg of pCAGIG_hTks4 plasmid. The mixture was incubated at room temperature for 15 min
and then added dropwise onto Tks4-KO cells. After 16 h, fresh media was added, and the cells were
incubated for an additional 24 h. The next day, the cells were washed with pre-warmed sterile PBS
(Sigma-Aldrich), followed by trypsinization and flow cytometry. 100,000 WT and 100,000 Tks4-KO
GFP-positive cells were collected and total RNA was isolated using the method described above.
2.8. Automated Microscopy
Recording of cellular behavior was performed in a time-lapse manner. Frames were collected via
a Leica DM IRB inverted microscope equipped with a motorized stage (Marzhauser SCAN-IM) and a
10× HC-PLAN objective (NA 0.25, working d: 11.0 mm). Frames were digitalized via an Olympus
DP70 CCD camera. For the entire duration of the recordings, the cells were maintained at 37 ◦C in a
5% CO2 atmosphere. Phase-contrast images from each microscopic field of view were collected every
10 min for durations up to 5 days post-seeding.
2.9. Segmentation of Cell Covered Area
The cell covered areas were identified by the presence of large local variability in brightness values
following a previously described method [42,43]. The segmentation and confluency calculating script
can be accessed at http://github.com/aczirok/cellconfluency. The cell clusters were detected and cluster
size distribution histograms were calculated by python scripts, available at github upon acceptance of
the manuscript.
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2.10. Optical Flow Analysis
Cell movements were calculated by optical flow analysis of consecutive image pairs (particle
image velocimetry, PIV) using the method described in [44,45].
2.11. Individual Cell Movement
Cells were tracked by a custom software, GTrack [46]. 20 WT and 20 Tks4-KO cells were followed
for 25 h in a timeframe corresponding to 60–85 h post-seeding. The motion of individual cells was
tracked following a previously described method [47,48].
2.12. Spheroid Formation
The spheroids were formed in agarose micromolds. Briefly, 2% boiling agarose solution (Invitrogen)
was poured into a PDMS template (3D Petri Dish, Microtissues). The agarose was then allowed to
gelate at −20 ◦C for 5 min. The resulting non-adherent agarose micromolds, each of which contained
35 wells with a diameter and depth of 800 µm, were placed in 35-mm culture dishes and equilibrated
in McCoy’s 5A cell culture medium for 1 h. Approximately 3000 cells in suspension were transferred
into each well, and then the wells were filled up with cell culture medium. The aggregation process
was followed via automated microscopy. Phase-contrast images of aggregates in each microscopic
field of view were collected every hour.
2.13. 3D Collagen Invasion Assay
Spheroids from WT and Tks4-KO cells were embedded in 1.7 mg/mL type I collagen (Corning) gels,
prepared following the manufacturer’s instructions. The gels were kept in 6 mm diameter poly-lactic
acid (PLA) wells, 3D printed on 35-mm culture dishes [49]. First, 30 µL collagen I solution was poured
into the wells and allowed to form a gel 0.5 mm thick at the center of the well. Then to each well, a few
spheroids were added within an additional 30 µL collagen I solution, which was poured on the top of
the first collagen I gel layers. After gelation 1 mm thick spheroid-containing collagen I sandwiches
were submerged in McCoy’s 5A culture medium and imaging was carried out as described above.
2.14. Statistical Analyses
Statistical analyses were performed using Student’s unpaired t-test following testing of the data
via the F-test to confirm normal distributions.
3. Results
3.1. Generation of Tks4 Knockout HCT116 Cells
Since the Tks scaffold proteins are involved in cellular migration, invasion, and the progression of
several cancer types, including colon cancer, we investigated the role of Tks4 in human colon cancer
HCT116 cells by knocking out its gene using the CRISPR/Cas9 system. The genetic alterations were
confirmed via sequencing of the affected genomic regions (Figure 1A). The modified exonal sequences
were inserted into the wild type open reading frame. Both modified alleles introduce a premature
stop codon, thus marking the transcripts for nonsense-mediated decay (Figure S2). The absence of
Tks4 in the cells was confirmed via Western blot analysis and immunocytochemistry. The Western blot
experiments showed that the Tks4-specific band present in the wild type cell lysate was nearly absent
in the Tks4-KO cell clone (Figure 1B).
In the first Western blot image shown in Figure 1B, a faint band in the position of Tks4 remains in
the Tks4-KO cell lysate. It is likely that the anti-Tks4 polyclonal antibody recognizes another protein
epitope on the gel with the same molecular weight as that of Tks4. To fully exclude the possibility that
the Tks4 knockout was not complete, we tested multiple antibodies and immunocytochemistry was
also performed (Figure 1B and Figure S3). DAPI staining was used to visualize the cell nuclei, and
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Tks4 was labeled with the anti-Tks4 antibody. Figure 1C shows that in WT cells, the Tks4 signal is
located abundantly in the cytosol, while it is completely absent in the Tks4-KO cells.Cells 2019, 8, x 6 of 18 
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Figure 1. Deletion of SH3PXD2B via CRISPR/Cas9 in HCT116 cells. (A) Human SH3PXD2B is located
on chromosome 5. Exon 2 is highlighted with a yellow background, the gRNA complement sequence
is underlined, and the PAM sequence is indicated with red nucleotides. SH3PXD2B knockout “Allele1”
contains a 17-bp long insertion, and “Allele2” contains a 7-bp deletion. (B) Validation of the absence of
Tks4 p otei via Western blotting, with multip e antibodies. (C) Representative fluorescent images of
wild type and Tks4-KO cell cultures. Nuclei were visualized with DAPI (blue), while Tks4 is shown in
green. Scale bar represents 10 µm.
3.2. Tks4-KO Cells Show Morpholog cal Changes and Increased Expressio of Fibronecti and Snail2
Transcription Factor
The initial examination of morphology in Tks4-KO cells showed elongated soma and decreased
circularity compared to the WT cultures (Figure 2A), changes strongly associated with the epithelial-to-
mesenchymal transition (EMT) in epithelial cells. Therefore, we investigated the expression and
localization of E-cadherin in WT and TKs4-KO cells. Figure 2A shows that both wild type and Tks4-KO
cells express E-cadherin, however, the expression pattern is gnificantly different. WT cells grow
in colonies; the cell–cell junctions were tight and syncytium-like structures were formed where the
inner boundaries were barely visible. However, in the KO colonies, the cell–cell contacts were more
prominent, and individual c lls could be easily identified. Furthermore, E-cadherin appear d to be
translocated to the cytosol, suggesti g that E-cadherin nternalization was trigger d in Tks4-KO cells
(Figure 2A).
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the E-cadherin protein levels via Western blotting. (E) Cellular adherence measurements. Center lines
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levels of the EMT-governing transcription factors Snail1 (SNAI1), Snail2 (SNAI2), and Twist (TWIST),
and the mesenchymal marker protein fibronectin (FN1). The error bars show the standard deviation,
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Palacios et al. demonstrated that, upon EMT, E-cadherin is internalized by lysosomes and not
recycled to the membrane. Depletion of the E-cadherin protein level ensures a lasting disruption
of cell−cell contacts and leads to a more motile phenotype [50]. Figure 2B,C demonstrates that in
Tks4-KO cells, the E-cadherin signal partly co-localizes with lysosomes. Analyzing the data with
Pearson’s correlation showed a correlation coefficient of 0.551 ± 0.120 in the Tks4-KO compared to
0.029 ± 0.014 in the WT. This finding suggests that E-cadherin is partially internalized and found
in acidic lysosomes. Western blotting with a second antibody revealed that E-cadherin is indeed
downregulated in Tks4-KO cells on the protein level (Figure 2D and Figure S4), thus supporting
increased motility in these cancer cells.
The conversion to the mesenchymal phenotype also involves a decrease in cell polarity and
increased detachment from the basal membrane [1,51,52]. Therefore, the effect of the absence of Tks4
on the cell-surface adhesion was investigated. Measuring fluorescence intensity of calcein labeled cells,
we found that the surface adhesion abilities of Tks4-KO were markedly reduced (Figure 2E).
To assess the changes in the EMT program in the Tks4-KO cells at the mRNA level, qPCR
experiments were conducted to measure the expression levels of the Snail1, Snail2, and Twist1
(henceforth referred to as Twist) transcription factors, and fibronectin (FN1), an ECM protein that is
an early hallmark of the EMT process. Figure 2F demonstrates that both fibronectin and Snail2 were
upregulated in the Tks4-KO cells. In contrast, we noticed that the levels of Snail1 and Twist were
slightly, but significantly downregulated in Tks4-KO cells compared to WT. These findings suggest
that loss of Tks4 in cancer cells can influence the expression levels of EMT-inducing transcription
factors and proteins. To ensure that the expression level changes observed in the qPCR experiments
also occurred at the protein level, immunocytochemistry and Western blotting were used. As seen
in Figure 2G, wild type HCT116 cells showed low fibronectin expression. In contrast, Tks4-KO cells
showed noticeable levels of fibronectin. Figure 2H also shows fibronectin upregulation in the KO cells,
while Snail1 downregulation can also be observed (Figure 2H and Figure S4). Taken together, these
findings indicate the initiation of a transition towards a more mesenchymal phenotype.
3.3. Tks4-KO Cells Showed Increased Motility and Detachment from Each Other in Monolayer Cultures
To test the functional role of Tks4 in HCT116 cells, we recorded monolayer cultures grown on
tissue culture plastic with an automated microscopy system. To investigate if Tks4-KO HCT116 cells
exhibit a mesenchymal phenotype with an increased motility, the speed of random two-dimensional
motility was estimated by calculating the optical flow with an automatic PIV analysis [44,45]. To avoid
the effects of crowding and confluence-induced senescence, data analysis was restricted to the first
100 h post-seeding. The PIV analysis indicated a statistically significant, ~30% increase in motility in
the case of Tks4-KO cells (Figure 3A and Figure S5A). This difference in motile activity was present
from seeding throughout the 100 h long observation period. As a complementary characterization to
the automatic PIV method, we manually tracked the trajectories of 20 WT and Tks4-KO cells using the
same image sequence. Cell trajectories were then statistically characterized by calculating their mean
net displacement for time windows of various durations (Figure 3B and Figure S5B). This measure
of motility also indicated a ~30% increase for Tks4-KO cells for displacements larger than 20 µm;
displacements larger than a cell and hence detected reliably by the human operator.
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significant differences between wild type and Tks4-KO cells are indicated at the bottom of the chart.
Dark and light gray dots represent a p-value lower than 0.05 and 0.01, respectively, obtained by unpaired
Student’s t-tests performed at each time point. (B) Net cell displacements during time intervals of
various durations. Twenty wild type and Tks4-KO cells were followed manually over a period of 25 h
post-seeding. Solid lines indicate the average while the shaded areas represent the SEM. The difference
between wild type and Tks4-KO cells is statistically significant for displacements larger than 20 µm.
Dark and light gray dots indicate p-values lower than 0.05 and 0.01, respectively, established by
unpaired Student’s t-tests performed at each time point. (C) Representative micrographs of cell clusters,
recorded at 0, 24, 48, 72 h post-theseeding. Scale bar represents 40 µm. (D) Frequency of cell clusters
categorized according to their area. Bar graphs display the average of three independent measurements,
statistical analysis was carried out by using unpaired Student’s t-test, error bars show SEM.
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We have shown earlier that in Tks4-KO cells the downregulation of E-cadherin has been initiated,
leading to a more mesenchymal morphology (Figure 2B,C). Accordingly, we evaluated the ability of
cells to form and remain in clusters, an important function of cadherins. Image sequences that were
recorded from WT and Tks4-KO cultures indicated the abundance of single cells and small clusters in
the Tks4-KO cultures, while wild type cells formed large clusters (Figure 3C). To quantify the difference,
we developed image processing tools to identify each cell cluster within the images. Our analysis
indicates that the overall proliferation rate and hence the increase in the cell-covered area is not affected
by the absence of Tks4 (Figure S6). Accordingly, cluster size distributions indicate an overall increase
in cluster size with time (Figure S7). This measure also indicates a subpopulation of Tks4-KO cells that
remain in small clusters. Cluster size distributions, pooled from parallel experiments, indeed indicate
an increase in the number of small clusters in Tks4-KO cultures (Figure S7). Overall, we identify a
two-fold increase in the frequency of clusters that fall within the 300–3000 µm2 range and thus likely
contain 1–10 cells (Figure 3D). This preponderance of smaller clusters can reflect increased detachment,
motility and decreased cell-cell adhesion. These findings, together with the partial internalization of
E-cadherin (Figure 2B,C) suggest that cell-cell connections are impaired in the absence of Tks4.
3.4. Tks4-KO Cells Show Decreased Spheroid Forming Potential and Display Increased Invasiveness in
Collagen Matrix
Metastasis formation requires cells to detach from the primary tumor, invade the microenvironment
and eventually enter and leave the circulation through the processes of intra- and extravasation.
The initial step of this process is governed by EMT, where one or multiple cancer cells from the
primary solid tumor undergo transition to acquire the motile and less restrained invasive mesenchymal
phenotype [4]. To investigate if Tks4-KO cells are indeed more invasive, spheroids were established
from both wild type and Tks4-KO cells and subsequently embedded into a 1 mm thick collagen-I gel.
We observed that Tks4-KO spheroids were less compact than the corresponding spheroids made
from WT cells. The aggregates are loose at seeding and gradually become more compact indicated
by the reduced overall size at 35 h post-seeding. Tks4-KO cells form an irregular perimeter with
loosely attached cell clusters (Figure 4A). To characterize spheroid compactness, we developed image
analysis tools to extract the shape of spheroids from micrographs. Each spheroid was characterized
by the value of its normalized perimeter: the ratio of the actual perimeter and the perimeter of a
circle with the same area. This quantitative measure was extracted from images recorded during the
aggregation process (Figure 4B and Figure S5C) as well as from 32 distinct aggregates (Figure S8). The
results indicate that wild-type spheroids reach a 50% more compact shape (normalized perimeter =
1.31 ± 0.02) than Tks4-KO cells do (normalized perimeter = 1.76 ± 0.16). The fact that Tks4-KO cells
remain in a loose aggregate further supports that cell-cell connections are weak and less functional in
the absence of Tks4.
To assess the role of Tks4 in tumor cell invasion, spheroids were embedded into a collagen I
matrix and cultures were recorded by automated microscopy. While both WT and Tks4-KO spheroids
expanded as cells invaded the collagen I gel, the Tks4-KO cultures exhibited more solitary cells and
small cell clusters within the collagen gel (Figure 4C, Video S1). To quantitatively characterize this
finding, we segmented the images and identified cell clusters that were not connected to the large
central aggregate. During the experiment, the area associated with such solitary clusters increased
gradually and reached a value two-fold higher in Tks4-KO cultures than in WT cultures (Figure 4D
and Figure S5D). Loss of Tks4, therefore, also correlates with a more solitary invasive phenotype in
HCT116 cells.
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3.5. Reintroducing Tks4 Rescues Altered FN1 and EMT Transcription Factor Expression Levels
To prove that the EMT-like phenotype seen in the KO cells was specifically due to lack of Tks4
rather than to stress responses or other off-target effects of the CRISPR/Cas9 system, HCT116 KO
cells were transfected with a Tks4 “rescue” expression plasmid (Figure 5A). Figure 5B shows that the
re-expression of Tks4 in the KO cells reverted the altered fibronectin (FN1), Snail1 (SNAI1), Snail2
(SNAI2) and Twist (TWIST) expression levels. To validate the success of our rescue experiment, we
checked the Tks4 levels in our KO_rescue cells via Western blotting. The results clearly show the
presence of the Tks4 protein in abundant levels (Figure 5C and Figure S9). The altered E-cadherin and
fibronectin expression levels were also reverted to the wild type levels following transfection with the
Tks4-encoding plasmid (Figure 5D and Figure S10). Since these reversions are coupled to the main
mediators and hallmark processes of the EMT program, we concluded that the observed changes were
linked to the absence of the Tks4 scaffold protein.
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Figure 5. Transfecti n of Tks4-KO cells with a Tks4 encoding plasmid. (A) Tks4 KO cells were
transien ly transfected with a Tks4 “rescue” expression plasmid. 24 h later, cells were harv sted and
subjected to qPCR analyses. The expression levels of Snail1 (SNAI1), Snail2 (SNAI2), Twist (TWIST),
and fibronectin (FN1) w re measured as describe t aterials and Methods. The rro bars show
the stand rd deviation, and the sta istical analyses were carried out using the unpaired Student’s t-test.
(B) Schematic diagram of he Tks4-encoding pCAGIG vector. (C) Western blot experim n s using WT,
KO and KO_rescue cell lysates with Tks4 antibody (D) Western blot experiments using WT, KO and
KO_rescue cell lysates with E-cadherin and Fibronectin antibodies.
4. Discussion
A contribution of Tks4 to cancer progression has been suggested in several cancer types, including
breast cancer [53], melanoma [27], acute myeloid leukemia [54], and prostate cancer [55]. Consistent
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with these links, a detailed analysis showed that Tks4 and its phosphorylation are implicated in
invadopodia formation in human colon cancer cells [56]. However, limited information is known
about how Tks4 is involved in cancer formation, especially in the epithelial context. Therefore, to
investigate the possible functions of Tks4 in detail, human HCT116 colon cancer cells were chosen as a
model system since they show functional invadopodia, indicating that they endogenously express
Tks4 (Figure 1B) [28,57]. They also express the Tks4-activating Src kinase [58] and can undergo partial
EMT [59].
Here we used the CRISPR/Cas9 system to knock Tks4 out and investigate the morphologic,
phenotypic and transcriptional changes which developed in the lack of the protein. Our results showed
that loss of Tks4 initiated EMT or EMT-like phenotypic and molecular changes in this human colorectal
carcinoma cell line. The mechanism by which the loss of Tks4 modulates this EMT-like process in tumor
cells remains obscure. One possible explanation is that Tks4 is involved in the regulation of cancer cell
motility, as indicated by its roles in EGFR signaling [24,60] an EMT-inducing molecular pathway. It has
been already shown that the induction of the EGF/EGFR axis can initiate EMT in cholangiocarcinoma
(CCA) cell lines and in the human embryonal rhabdomyosarcoma cell line [61]. In these experiments,
increases in the Snail2/Slug and ZEB1 levels were observed upon EGF stimulation. Another group
found that EGF upregulates Snail1/2 and ZEB1 expression but does not affect Twist in serous borderline
ovarian tumor cells (SBOT) [62]. Both of these publications also mentioned that EGFR induction
decreased E-cadherin levels. We assume that the lack of Tks4 likely alters EGFR signaling in these cells,
perhaps resulting in a shift toward a mesenchymal-like motile phenotype. Moreover, due to the loss
of Tks4 having similar effects on cancer cells as EGF treatment (EMT induction, reduced E-cadherin
expression), it is possible that Tks4 plays a putative negative regulatory role in the EGFR pathway by
delaying signal transduction or changing its kinetics.
Another possible mechanism by which Tks4 could participate in these EMT-like changes relies
on the fact that Tks4 is part of a reactive oxygen species (ROS)-producing protein complex. An early
observation from Gianni et al. showed that NoxA1 (NADPH oxidase activator subunit) and Tks4
can interact and that their phosphorylation status influences ROS production [56]. Since ROS is an
important player in EMT in colon cancer cells [63,64], we propose that if the signaling pathway that
converges on the Tks4 scaffold protein is disturbed, the balanced ROS level is also shifted leading to
EMT-associated mechanisms.
A possible role of the Tks scaffold protein family in the formation of invadopodium and metastasis
was proposed recently [27]. Invadopodia are actin-rich membrane protrusions, which are instruments
of cellular invasion via ECM degradation. As described previously, the loss of Tks5 (a close relative
of Tks4) completely diminishes invadopodium formation, while the absence of Tks4 negates ECM
decomposition. Specifically, Tks4 as a critical invadopodium marker protein has been also connected
to cancer and was used to monitor the invasiveness of colon and breast cancer cells both in vitro and
in vivo [47,50]. These seemingly controversial functions of Tks4 could be explained by the theoretical
multi-purpose nature of the protein. It is possible that temporary loss of Tks4 has a significant effect
on cell migration, which heavily depends on podosome formation, while the permanent absence
of the protein in epithelial cells increases their invasiveness by activating an EMT-like program.
We hypothesize that the loss of Tks4 has different effects in epithelial and mesenchymal cells. Previous
studies used mesenchymal or non-epithelial cell lines to study the effects of Tks4 knockout [23,27,65],
and stable and complete knockout of Tks4 in epithelial cells has never been achieved or published
before according to our knowledge. We are not challenging the role of Tks4 in podosome/invadosome
formation. Instead, we are reporting new and important, but also different, functions for this protein
in the regulation of cell morphology and behavior. Based on the available data related to the roles of
Tks4 in development, disease, and cancer cell behavior, it appears that Tks4 is important for podosome
formation and invasion; however, stable and complete absence of the protein in epithelial cells initiates
EMT-like changes.
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Despite the concordant results included in the current article, there are several limitations that
have to be reckoned with in our study. The experiments were performed on only one epithelial cell
line (HCT116), however, the same results were obtained from several clones after Tks4 knock out.
The selected cell line has a known deficiency in the epithelial-to-mesenchymal transition process, which
makes it an imperfect candidate to study full-blown EMT [59]. Unfortunately, we were not aware of
the surprising effect of the absence of Tks4 on EMT at the time we established the cell line. We did
not conduct experiments where the EGF or any other possibly affected pathways were disrupted to
reveal a plausible mechanistic link between the loss of Tks4 and EMT. Finally, the current study lacks
animal experiments to prove the increased EMT-mediated in vivo invasiveness of the newly established
cell line.
Our results suggest a novel role for Tks4. Given the fact that Tks4 is a scaffold protein without
known enzyme activity, the significant changes caused by its loss of function are quite surprising.
Knowing how important EGFR signaling and mutations are in physiological and pathological processes,
we can presume that a protein involved in this pathway has a critical role to play also. Mutations
of Tks4 are associated with the rare but severe Frank-ter Haar syndrome. Patients affected by this
congenital disease always show developmental abnormalities, therefore the involvement of an altered
EGFR pathway could be also suspected. Though the mechanism which interconnects loss of Tks4
and EMT induction has yet to be understood, our results clearly show a correlation between the two.
We propose that Tks4 and its downstream signaling partners are important modulators of the EMT
process at the gene expression level. Our hypothesis that Tks4 is a novel molecular regulator of EMT
via its roles in altering the expression levels of EMT master regulators warrants further examination.
As our results suggest, the absence of Tks4 in epithelial cancer cells can lead to EMT-like features,
increased motility and spreading; therefore, targeting the protein or stabilizing its expression levels
could be beneficial strategies for future anti-cancer therapies.
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